Transient elastography for diagnosis of portal hypertension in liver cirrhosis: Is there still a role for hepatic venous pressure gradient measurement?

Hepatology

Volumn 45, Issue 5, 2007, Pages 1087-1090

  Lim, Joseph K ^b   Groszmann, Roberto J ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ECHOGRAPHY; EDITORIAL; ESOPHAGUS VARICES; HEPATIC VEIN; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; PORTAL HYPERTENSION; PRESSURE GRADIENT; PRIORITY JOURNAL; SCREENING TEST; TRANSIENT ELASTOGRAPHY; ULTRASOUND; VENOUS PRESSURE;

BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; ELASTICITY; HEPATIC VEINS; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS;

EID: 34248664736     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21731     Document Type: Editorial

References (29)

1. Dufour MC. Chronic liver disease and cirrhosis. In: Everhart JE, editor. Digestive diseases in the United States: epidemiology and impact. Washington, DC: US Dept of Health and Human Services, 1994;615-45. NIH publication no. 94-1447.
2. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. HEPATOLOGY 2002;36:227-242.
3. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al; The Portal Hypertension Collaborative Group. Hepatic venous pressure cgadient (HVPG) predicts clinical decompensation in patients with compensated cirrhosis [Abstract]. HEPATOLOGY 2006;44(Suppl):203A.
4. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344: 495-500.
5. Terreni M, Radaelli, Padalino R, Toldi A, Gualdoni G, Casiraghi MA, et al. Is liver biopsy routinely required before interferon treatment for chronic HCV hepatitis? Am J Gastroenterol 2000;95:2521.
6. van Leeuwen DJ, Howe SC, Scheuer PJ, Sherlock S. Portal hypertension in chronic hepatitis: relationship to morphologic changes. Gut 1990;31:339-343.
7. Burroughs AK, Groszmann R, Bosch J, Grace N, Garcia-Tsao G, Patch D, et al. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? Gut 2002;50:425-427.
8. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. HEPATOLOGY 2003;38:518-526.
9. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. HEPATOLOGY 2006;1317-1325.
10. Patel K, Gordon SC, Jacobson I, Hezode C, Oh E, Smith KM, et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004;41:935-942.
11. Mukherjee S, Sorrell MF. Noninvasive tests for liver fibrosis. Sem Liver Dis 2006; 26:337-47.
12. Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R,et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. HEPATOLOGY 2005; 42:838-845.
13. Nahon P, Thabut G, Ziol M, Htar MT, Cesaro F, Barget N, et al. Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C. Am J Gastoenterol 2006;101:2744-2751.
14. Gomez-Dominguez E, Mendoza J, Rubio S, Moreno-Monteagudo JA, Garcia-Buey L, Moreno-Otero R. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharm Ther 2006;24:513-518.
15. Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. HEPATOLOGY 2006;44:1511-1517.
16. Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouilleres O, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. HEPATOLOGY 2006;43:1118-1124.
17. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (Fibroscan) : a prospective study. Gut 2006;55:403-408.
18. de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. JAIDS 2006; 41:175-179.
19. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. HEPATOLOGY 2005;41:48-54.
20. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-350.
21. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. HEPATOLOGY 2007:45:1290-1297.
22. Kazemi F, Kettaneh A, N'kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006;45:230-235.
23. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transplant 2006;12:1791-1798.
24. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. HEPATOLOGY 2004;39:280-283.
25. Groszmann RJ, Abraldes JG. Portal hypertension: from bedside to bench. J Clin Gastroenterol 2005;39(Suppl):S125-S130.
26. de Franchis R, Dell'Era A, Iannuzzi F. Diagnosis and treatment of portal hypertension. Dig Liver Dis 2004;36:787-798.
27. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001;358:958-965.
28. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982.
29. Foucher J, Castera L, Bernard PH, Adhoute X, Laharie D, Bertet J, et al. Prevalence and factors associated with failure of liver stiffness measurement using Fibroscan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006;18:411-12.